Ondansetron Teva

Ondondansetron, the active ingredient in Ondansetron Teva, is a 5-HT3 receptor antagonist presented as a tablet for oral use. It helps prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron Teva works ​​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​    t   t   t

-  Chemotherapy‑induced nausea and vomiting:  Prevents  and  controls  the  onset  of  nausea  and  vomiting  in  patients  receiving  chemotherapy  t     -  Radiation‑           ... (etc)

???

...